PURE Bioscience, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
PURE Bioscience, Inc. (PURE) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $106.70 million as of 2024-07-31, per its 10-K filed 2025-10-29.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2025-10-29
- 2024-07-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $106.70M; Deferred Tax Assets, Operating Loss Carryforwards, Domestic as first filed $107.20M.
- 2023-07-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $66.80M; Deferred Tax Assets, Operating Loss Carryforwards, Domestic as first filed $110.50M.
- 2022-07-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $107.30M.
- 2021-07-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $107.50M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic as first filed |
|---|---|---|
| 2024-07-31 | $106.70M 10-K · filed 2025-10-29 | $107.20M 10-K · filed 2024-10-29 |
| 2023-07-31 | $66.80M 10-K · filed 2025-10-29 | $110.50M 10-K · filed 2023-10-30 |
| 2022-07-31 | $107.30M 10-K · filed 2022-10-28 | |
| 2021-07-31 | $107.50M 10-K · filed 2021-10-28 | |
| 2020-07-31 | $106.20M 10-K · filed 2021-10-28 | |
| 2019-07-31 | $108.30M 10-K · filed 2020-10-08 | |
| 2018-07-31 | $105.20M 10-K · filed 2019-10-30 | |
| 2017-07-31 | $100.30M 10-K · filed 2018-10-25 | |
| 2016-07-31 | $95.40M 10-K · filed 2017-10-26 | |
| 2015-07-31 | $90.20M 10-K · filed 2016-10-27 |